Advertisement
U.S. markets closed
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • Dow 30

    39,807.37
    +47.29 (+0.12%)
     
  • Nasdaq

    16,379.46
    -20.06 (-0.12%)
     
  • Russell 2000

    2,124.55
    +10.20 (+0.48%)
     
  • Crude Oil

    83.11
    +1.76 (+2.16%)
     
  • Gold

    2,254.80
    +42.10 (+1.90%)
     
  • Silver

    25.10
    +0.35 (+1.41%)
     
  • EUR/USD

    1.0792
    -0.0037 (-0.35%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • GBP/USD

    1.2624
    -0.0014 (-0.11%)
     
  • USD/JPY

    151.3750
    +0.1290 (+0.09%)
     
  • Bitcoin USD

    70,785.66
    +1,753.49 (+2.54%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

TearLab 4Q loss widens as expenses climb

TearLab 4th-quarter loss widens as operating expenses rise

SAN DIEGO (AP) -- TearLab's fourth-quarter loss widened as operating expenses rose.

Its loss was larger than Wall Street expected and its shares slipped 2 percent in morning trading Wednesday.

The San Diego company, which provides diagnostic tests for eyes, lost $3.7 million, or 13 cents per share, for the three months ended Dec. 31. That compares with a loss of $3.5 million, or 17 cents per share, a year earlier.

Analysts surveyed by FactSet expected a smaller loss of 11 cents per share.

Total operating expenses increased to $4 million from $2.8 million.

Revenue more than tripled to $1.6 million from $499,000, meeting Wall Street's expectations.

The company reported 232 system orders booked in the quarter.

For the year, TearLab Corp. lost $19.3 million, or 76 cents per share. In the previous year it lost $8.8 million, or 50 cents per share. Annual revenue nearly doubled to $4 million from $2.1 million.

Shares fell 13 cents, or 2.1 percent, to $6.20 in mid-morning trading. Over the past year, the stock has traded in a range of $2.57 to $6.61 per share.

Advertisement